Cited by 8Mental Health Treatment and AccessSchizophrenia research and treatmentPsychology and Mental Health

Reducing Stigma Among Youth at Risk for Psychosis: A Call to Action

Open access
DeLuca, Joseph S, Yang, Lawrence H, Lucksted, Alicia A, Yanos, Philip T, DeVylder, Jordan, Anglin, Deidre M, Landa, Yulia, Corcoran, Cheryl M·2021·Schizophrenia Bulletin

Abstract

Stigma and discrimination toward people with serious mental health conditions continues to be a pressing social problem in the United States and globally.1 Youth at clinical high risk for psychosis (CHR-P) experience subthreshold but impactful psychotic experiences,2 and experience more internalized stigma and perceive more discrimination than adolescent outpatients with other severe mental health conditions.3 Although CHR-P labeling can lead to positive effects (validation, relief, connection to specialized services), both CHR-P labeling and symptom experiences may also catalyze stigmatization (by peers, family, school and job associates, health providers, one’s self), which can contribute to distress, fear, suicidality, withdrawal, poor engagement with services, and even conversion to psychosis.3 Studies to date suggest that standard psychosocial treatments do not fully mitigate the negative effects of stigma for youth at CHR-P.4 Here we wish to draw attention to the clinical need for CHR-P stigma-related interventions that are rooted in adolescent and young-adult developmental science. Furthermore, given that youth at CHR-P are diverse and often report discrimination related to other stigmatized identities,5,6 we contend that such initiatives also must be informed by an intersectional social identities’ framework.7 Worldwide efforts are ongoing to prevent or delay the onset of psychosis among youth at CHR-P. Approximately 22%–38% of youth at CHR-P develop a psychotic disorder, with high comorbidity of depressive and anxiety disorders.8 Given these diverse clinical presentations and trajectories, CHR-P programs employ transdiagnostic and needs-based care. An empirically driven, adjunctive focus within these programs on reducing the harmful effects of stigma experiences is urgently needed.9 There are several unique considerations in working to address that need. First, an adolescence and young adulthood developmental lens is needed to understand the dynamics among stigma experiences and concerns and the youth’s family, peers, and emerging self-concept and functional development. Future research must inquire into these domains and consider, eg, potential identity disruptions10; the inclusion of peer support, broader family support, and related stigma reduction strategies within this work11,12; and the integration of this work into schools and around issues such as bullying.13 This lens must be combined with centering young people’s experiences and meaning-making in this inquiry. Related, recent research has found that stigma experiences differ cross-culturally and can be quite nuanced for youth and families, eg, with Latinx youth at CHR-P anticipating more rejection and expressing more secrecy, but also engaging in more empowerment-related coping.14 Second, it is imperative for the field to more deeply understand the multifaceted impacts of CHR-P and other mental health experiences for these youth. Yang et al15 have found that most youth at CHR-P identify nonpsychotic disorders (depression, anxiety) as having the “greatest subjective impact” on their sense of self (vs CHR-P labels). Additionally, it was found that the “psychosis risk” label had more impact on youth at CHR-P who thought they were at risk for psychosis or had been told they were at risk.15 Thus, Yang, Corcoran, and colleagues’ work9,15 highlights important considerations in CHR-P stigma research. More studies are needed to disentangle stigma related to various psychiatric labels and symptoms, including whether internalized CHR-P stigma is related to fear of developing psychosis and/or current symptoms, as well as the myriad social experiences related to these labels, symptoms, and mental health treatment.3 These aspects must also be considered when developing key components of stigma-resilience and other CHR-P interventions. Third, as noted, youth at CHR-P often report experiencing more discrimination related to nonpsychiatric identities than nonpsychiatric controls, such as about their appearance, ability status, religion, and sexual orientation.6 Notably, perceived discrimination was not associated with CHR-P symptoms in this study, but it was associated with negative schemas about self and others. Other formative research, examining racial discrimination and social determinants of health, similarly highlights that youth at CHR-P often contend with the management of multiple stigmatized identities.5 How this interacts with mental-illness-related stigmatization, regarding synergistic stress and/or coping, is unknown. To our knowledge, no intervention study has been conducted to specifically target the personal impacts of stigma experiences among youth at CHR-P. Morrison et al4 compared individual cognitive therapy plus symptom monitoring (CT+SM) to SM only and found through secondary data analysis that a measure of internalized stigma (negative appraisals of and beliefs about psychiatric experiences) decreased over a 2-year period for both g

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/schbul/sbab098

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
DeLuca, J. S., Yang, L. H., Lucksted, A. A., Yanos, P. T., DeVylder, J., Anglin, D. M., Landa, Y., & Corcoran, C. M.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • New York University (US)
  • University of Maryland, Baltimore (US)
  • The Graduate Center, CUNY (US)
  • Fordham University (US)
  • City College of New York (US)
Corresponding author
DeLuca, Joseph S
Venue
Schizophrenia Bulletin
Published
2021-08-17
Volume
47
Issue
6
Pages
1512-1514
ISSN
  • 0586-7614 (ISSN-L)
  • 1745-1701
OpenAlex
W3195901218
Cited by
8
References
20
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 2
Type
journal article
Language
en
Open access
Locations
  • Schizophrenia Bulletin (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1T32MH122394-01)
  • National Institute of Mental Health
Topics
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Psychology and Mental Health
Keywords
stigma reduction
MeSH terms
Psychosocial Intervention, Adolescent, Disease Susceptibility, Humans, Psychotic Disorders, Risk, Self Concept, Social Stigma, Prodromal Symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review